CN104606521A - 治疗慢性肾功能衰竭的药物 - Google Patents
治疗慢性肾功能衰竭的药物 Download PDFInfo
- Publication number
- CN104606521A CN104606521A CN201310562672.7A CN201310562672A CN104606521A CN 104606521 A CN104606521 A CN 104606521A CN 201310562672 A CN201310562672 A CN 201310562672A CN 104606521 A CN104606521 A CN 104606521A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- medicament
- renal failure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 14
- 208000020832 chronic kidney disease Diseases 0.000 title claims abstract description 9
- 208000022831 chronic renal failure syndrome Diseases 0.000 title claims abstract description 8
- 239000009636 Huang Qi Substances 0.000 claims abstract description 5
- 239000002775 capsule Substances 0.000 claims abstract description 3
- 239000002552 dosage form Substances 0.000 claims abstract description 3
- 239000007788 liquid Substances 0.000 claims abstract description 3
- 210000000582 semen Anatomy 0.000 claims description 8
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 17
- 210000004369 blood Anatomy 0.000 abstract description 17
- 210000003734 kidney Anatomy 0.000 abstract description 11
- 210000000952 spleen Anatomy 0.000 abstract description 7
- 238000010792 warming Methods 0.000 abstract description 5
- 238000001631 haemodialysis Methods 0.000 abstract description 4
- 230000000322 hemodialysis Effects 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 2
- 235000008216 herbs Nutrition 0.000 abstract 2
- 241001671653 Aconitum carmichaelii Species 0.000 abstract 1
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 abstract 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract 1
- 241000759833 Cornus officinalis Species 0.000 abstract 1
- 240000007890 Leonurus cardiaca Species 0.000 abstract 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 abstract 1
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 240000004980 Rheum officinale Species 0.000 abstract 1
- 235000008081 Rheum officinale Nutrition 0.000 abstract 1
- 241001404789 Smilax glabra Species 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 description 16
- 235000019634 flavors Nutrition 0.000 description 16
- 235000009508 confectionery Nutrition 0.000 description 10
- 206010030113 Oedema Diseases 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 210000001015 abdomen Anatomy 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 230000001684 chronic effect Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 239000000341 volatile oil Substances 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 206010013990 dysuria Diseases 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 229930182558 Sterol Natural products 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 150000003797 alkaloid derivatives Chemical class 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 150000003432 sterols Chemical class 0.000 description 3
- 235000003702 sterols Nutrition 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- TYPSVDGIQAOBAD-DZGCQCFKSA-N Atractylone Chemical compound C([C@]1(C)C2)CCC(=C)[C@@H]1CC1=C2OC=C1C TYPSVDGIQAOBAD-DZGCQCFKSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 206010016326 Feeling cold Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- COBBNRKBTCBWQP-UHFFFAOYSA-N Graveoline Chemical compound C1=C2OCOC2=CC(C=2N(C3=CC=CC=C3C(=O)C=2)C)=C1 COBBNRKBTCBWQP-UHFFFAOYSA-N 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- WNGSUWLDMZFYNZ-UHFFFAOYSA-N Leonurine Chemical compound COC1=CC(C(=O)OCCCCN=C(N)N)=CC(OC)=C1O WNGSUWLDMZFYNZ-UHFFFAOYSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- HLXRWTJXGMHOFN-XJSNKYLASA-N Verbenalin Chemical compound O([C@@H]1OC=C([C@H]2C(=O)C[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HLXRWTJXGMHOFN-XJSNKYLASA-N 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 238000009738 saturating Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- XFSBVAOIAHNAPC-XTHSEXKGSA-N 16-Ethyl-1alpha,6alpha,19beta-trimethoxy-4-(methoxymethyl)-aconitane-3alpha,8,10alpha,11,18alpha-pentol, 8-acetate 10-benzoate Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-XTHSEXKGSA-N 0.000 description 1
- HOMSOWZTBJWNHP-UHFFFAOYSA-N 5-chlorothiadiazole Chemical compound ClC1=CN=NS1 HOMSOWZTBJWNHP-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- XFSBVAOIAHNAPC-UHFFFAOYSA-N Aconitin Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- NWUMSRKLBRWRAS-UHFFFAOYSA-N Arundoin Natural products COC1CCC2(C)C(CCC3C2=CCC4(C)C5CC(C)(C)CCC5(C)CCC34C)C1(C)C NWUMSRKLBRWRAS-UHFFFAOYSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- MRNPHCMRIQYRFU-UWAWSDATSA-N Cylindrin Chemical compound C([C@@]1(C)[C@H](C(C)C)CC[C@@H]1[C@@]1(C)CC=C23)C[C@@]1(C)[C@@H]3CC[C@@H]1[C@]2(C)CC[C@H](OC)C1(C)C MRNPHCMRIQYRFU-UWAWSDATSA-N 0.000 description 1
- BRQBMPGDACUHNR-UHFFFAOYSA-N Cylindrin Natural products COC1CCC2(C)C(CCC3C2=CCC4(C)C5CCC(C(C)C)C5CCC34C)C1(C)C BRQBMPGDACUHNR-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- DPMGVDIWDTYPMP-UHFFFAOYSA-N Hypaconitine Natural products COCC12CCC(OC)C3(CN(C)C1)C4CC5(O)C(OC)C(O)C(CC(OC)C23)(OC(=O)C)C4C5OC(=O)c6ccccc6 DPMGVDIWDTYPMP-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- HLXRWTJXGMHOFN-UHFFFAOYSA-N Verbenalin Natural products C12C(C)CC(=O)C2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O HLXRWTJXGMHOFN-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229940039750 aconitine Drugs 0.000 description 1
- STDXGNLCJACLFY-UHFFFAOYSA-N aconitine Natural products CCN1CC2(COC)C(O)CC(O)C34C5CC6(O)C(OC)C(O)C(OC(=O)C)(C5C6OC(=O)c7ccccc7)C(C(OC)C23)C14 STDXGNLCJACLFY-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- TYPSVDGIQAOBAD-UHFFFAOYSA-N atractylone Natural products C1C2(C)CCCC(=C)C2CC2=C1OC=C2C TYPSVDGIQAOBAD-UHFFFAOYSA-N 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- 239000001654 beetroot red Substances 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 108010089310 cylindrin Proteins 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- FIDOCHXHMJHKRW-GKVQVCCJSA-N hypaconitine Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@]45[C@@H](OC)CC[C@@]6([C@H]4[C@@H](OC)[C@H]([C@@](OC(C)=O)([C@H]31)[C@@H](O)[C@H]2OC)[C@H]5N(C)C6)COC)C(=O)C1=CC=CC=C1 FIDOCHXHMJHKRW-GKVQVCCJSA-N 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000003818 metabolic dysfunction Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- VDYCLYGKCGVBHN-UHFFFAOYSA-N pachymaic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C VDYCLYGKCGVBHN-UHFFFAOYSA-N 0.000 description 1
- SRDNLMOBFKJOSD-UHFFFAOYSA-N pachymic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C(O)=O)C(O)CC21C SRDNLMOBFKJOSD-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- -1 rehmanin Natural products 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 150000005856 steroid saponins Chemical class 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗慢性肾功能衰竭的药物,属于中药制剂技术领域。它主要由西洋参、黄芪、附子、茯苓、土茯苓、山茱萸、益母草、泽泻、大黄等16种药物构成,用制药设备器械炮制合格后制成胶囊、片剂、丸剂、颗粒、口服液不同剂型使用。本发明具有补气益肾,活血化瘀,温阳健脾,化浊利水的功效,对慢性肾衰有较好的治疗效果,能减少患者血透的时间、次数和减轻经济负担。
Description
技术领域
本发明属于中药制剂技术领域。
背景技术
慢性肾功能衰竭是发生在各种慢性肾脏疾病基础上缓慢出现的慢性肾功能减退直至衰竭的一种临床综合症。其主要表现为多种代谢功能障碍及由于代谢产物潴留所产生的各系统症状。现代医学对慢性肾衰的治疗一般都是服用中西药物,但疗效并不理想。也有部分患者采用腹透、血透、换肾等疗法以维持和延长生命,但这些疗法所需费用大,一般患者难以坚持治疗。
发明内容
本发明的目的是克服现有技术的不足,提供一种新的治疗慢性肾功能衰竭的药物。它具有补气益肾,活血化瘀,温阳健脾,化浊利水的功效,对治疗慢性肾衰有良好效果。能达到疗效确切,减少患者血透、腹透次数和降低经济压力的目的。
本发明解决其技术问题所采用的技术方案是:由西洋参、黄芪、附子、茯苓、土茯苓、山茱萸、益母草、泽泻、熟地黄、丹参、白茅根、肉桂、车前子、黑豆、大黄、白术16种原料药构成。
本发明制剂中有关药物成分主要功能与配制。
本发明中的西洋参,性味苦、微甘,寒。含甙类,皂甙,挥发油,树脂,淀粉,糖分等。补肺阴,清火生津液。主治久咳肺痿,虚热烦倦,口渴少津,胃火牙痛。
本发明中的黄芪,性味甘,微苦。含胆碱,甜菜碱,氨基酸,糖类等。补气固表,托毒生肌。主治表虚自汗,盗汗,气虚血脱,脾虚泄泻,痈疽不潰或潰不收敛,及一切元气不足之症。
本发明中的附子,性味辛,大热,有毒。含乌头碱,次乌头碱,脂类成分等。回阳,温里逐寒,止痛。主治亡阳虚脱,四肢厥冷,汗出脉微,虚寒泄泻,脘腹冷痛,寒湿痹痛,阳虚水肿,心力衰竭,慢性水肿。
本发明中的茯苓,性味甘、淡,平。含茯苓酸,麦角甾醇,胆碱,蛋白质,卵磷脂、脂肪等。渗湿利水,安心神,益脾胃。主治脾虚湿胜,水肿胀满,痰饮咳逆,呕秽泄泻,小便不利。
本发明中的土茯苓,性味甘、淡,平。含多种甾体皂甙,生物碱,挥发油,糖类,鞣质,树脂,甾醇,淀粉等。利湿,解毒。主治杨梅毒疮,筋骨挛痛,瘰疬痈肿,解汞毒。
本发明中的山茱萸,性味酸、涩,微温。含山茱萸甙,皂甙,鞣质,树脂,糖类等。温补肝肾,涩精,止汗。主治阳痿遗精,腰膝酸痛,小便频数,自汗。
本发明中的益母草,性味辛、苦,微寒。含益母草碱,芸香碱,甾醇,有机酸,糖类等。祛瘀生新,调经消水。主治月经不调,胎漏难产,胎衣不下,产后淤血,腹痛症瘕,小便不利,浮肿。
本发明中的泽泻,性味甘,微寒。含挥发油,生物碱,糖类,天门冬素,树脂等。渗湿利尿。主治膀胱湿热,小便不利,水肿胀满,泻痢,淋浊。
本发明中的熟地黄,性味甘、微苦,微温。含甘露醇,葡萄糖,生物碱,脂肪酸,地黄素,甾醇等。滋阴补肾,补血调血。主治阴虚血少,精亏劳损,腰酸头昏,耳聋,月经不调,崩漏,须发早白。
本发明中的丹参,性味苦,微温。含丹参酮,维生素E等。去瘀生新,活血调经,安神宁心,益气养血。主治心绞痛,心腹邪气,月经不调,痛经,经闭,淤血腹痛。
本发明中的白茅根,性味甘,寒。含甘露醇,葡萄糖,果糖,蔗糖,柠檬酸,苹果酸,白茅素等。清热凉血,利水通淋。主治内热烦渴,吐血衄血,小便不利,热淋尿血。
本发明中的肉桂,性味辛、甘,大热。含挥发油,粘液质,鞣酸,树脂等。温中,散寒,止痛。主治命门相火不足,肢冷脉微,胃寒腹痛吐泻,腰膝冷痛,阴疽疝瘕,虚阳上浮,上热下寒。
本发明中的车前子,性味甘,寒。含脂肪油,粘液质,车前子酸,胆碱等。利水,清热,明目。主治淋浊,癃闭,尿血,暑湿泻痢,目赤障翳。
本发明中的黑豆,性味甘,温。主宽中下气,利于调养大肠,消水肿肿毒。
本发明中的大黄,性味苦,寒。含大黄素,大黄酸,乳汁,没食子酸,粘液质,糖类等。泻实热,破积滞,行淤血。主治实热便秘,谵语发狂,食积痞满,痢疾初起,腹痛后重,实热发黄,经闭,症瘕,痈肿疔毒,烫火灼伤。
本发明中的白术,性味苦、甘,寒。含挥发油,主要为苍术醇,苍术酮,维生素A等。补脾,燥湿,和中。主治脾虚劳倦,食少泄泻,水肿,痰饮,自汗,胎动不安,脘腹虚胀等。
慢性肾功能衰竭病程长,是各种肾脏疾病发展的终末期,既有正气的损耗,又有邪毒瘀滞,属本虚表实,虚实夹杂之症。常因失治误治,导致肾阳衰微,真阴亏耗,致使肾脏功能日益衰退,气血阴阳虚惫,病症多发且危重。表现为疲乏厌食,头痛,恶心呕吐,腹痛,躁动不安,出现深而长的呼吸。严重者可出现心力衰竭,血压下降,昏迷和心跳停止。患者大多需腹透、血透、肾脏移植来维持和延长生命。但这些技术需要较大数量的经费,使一些经济困难患者无法坚持使用。本发明具有补气益肾,活血化瘀,温阳健脾,化浊利水的功效,对慢性肾衰有较好的疗效。本发明的有益效果是经临床应用证明对治疗慢性肾衰疗效确。能减轻患者的经济负担。
具体实施方式
1.配方及重量比例:西洋参15份、黄芪30份、附子15份、茯苓15份、土茯苓15份、山茱萸12份、益母草30份、泽泻18份、熟地黄20份、丹参15份、白茅根30份、肉桂12份、车前子20份、黑豆20份、大黄15份、白术12份。、
2.制作方法:将上述原料药按比例称量配齐,用制药设备器械炮制合格,提纯,浓缩,混合均匀后制成胶囊、片剂、丸剂、颗粒、口服液不同剂型备用。
Claims (1)
1.一种治疗慢性肾功能衰竭的药物,其特征是配方及重量比例是西洋参15份、黄芪30份、附子15份、茯苓15份、土茯苓15份、山茱萸12份、益母草30份、泽泻18份、熟地黄20份、丹参15份、白茅根30份、肉桂12份、车前子20份、黑豆20份、大黄15份、白术12份;将上述原料药按比例称量配齐,用制药设备器械炮制合格,提纯浓缩、混合均匀后加工成胶囊、片剂、丸剂、颗粒、口服液不同剂型。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310562672.7A CN104606521A (zh) | 2013-11-04 | 2013-11-04 | 治疗慢性肾功能衰竭的药物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310562672.7A CN104606521A (zh) | 2013-11-04 | 2013-11-04 | 治疗慢性肾功能衰竭的药物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104606521A true CN104606521A (zh) | 2015-05-13 |
Family
ID=53141342
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310562672.7A Pending CN104606521A (zh) | 2013-11-04 | 2013-11-04 | 治疗慢性肾功能衰竭的药物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104606521A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106177363A (zh) * | 2016-08-30 | 2016-12-07 | 吉林省中医药科学院 | 能够延缓慢性肾功能衰竭的中药 |
-
2013
- 2013-11-04 CN CN201310562672.7A patent/CN104606521A/zh active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106177363A (zh) * | 2016-08-30 | 2016-12-07 | 吉林省中医药科学院 | 能够延缓慢性肾功能衰竭的中药 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102068641B (zh) | 一种治疗妇科疾病的中药胶囊 | |
| CN103977358A (zh) | 一种降脂护肝的口服中药 | |
| CN101961458B (zh) | 一种治疗股骨头坏死的内服药物 | |
| CN103055129B (zh) | 一种治疗高血脂症的中药制剂 | |
| CN102512632A (zh) | 一种治疗月经不调的中药组合物 | |
| CN101204481A (zh) | 一种治疗慢性肾炎的中药 | |
| CN104922281A (zh) | 一种治疗慢传输型便秘贴敷药膏的中药组方及其制备方法 | |
| CN102895610A (zh) | 一种治疗水肿的药物 | |
| CN104784538B (zh) | 一种治疗糖尿病的中药制剂及制备方法 | |
| CN103990058A (zh) | 通经保元膏 | |
| CN102366617A (zh) | 一种治疗特发性水肿的中成药 | |
| CN101422547B (zh) | 一种治疗肾虚血亏型闭经的中药 | |
| CN104906507A (zh) | 一种降低血压、调理体质的中药组合物 | |
| CN105362682A (zh) | 一种治疗月经过少的外用药物 | |
| CN103961658A (zh) | 一种降脂护肝的胶囊制剂 | |
| CN104511001A (zh) | 治疗脾肾阳虚证肾病综合征的药物 | |
| CN103656565A (zh) | 一种治疗气阴两虚型心肌梗死的药物 | |
| CN103505579A (zh) | 一种减肥膏药组方 | |
| CN102552629B (zh) | 一种治疗风寒湿痹症的中药 | |
| CN103550437B (zh) | 一种治疗肝肾阴虚的中药组合物 | |
| CN101647965A (zh) | 一种治疗慢性肾炎的内服药物 | |
| CN102380010A (zh) | 一种治疗特发性水肿的中药配方 | |
| CN101985005A (zh) | 治疗月经不调的中草药 | |
| CN106361881A (zh) | 一种用于治疗阴囊湿疹的汤剂药物及其制备方法 | |
| CN104623387A (zh) | 一种用于治疗慢性肾炎的药物组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150513 |
|
| WD01 | Invention patent application deemed withdrawn after publication |